SynAct Pharma Completes SEK 51.9 Million Directed Share Issue

Maha Kanaan Europe Legal Chronicle
Tagged:

MAQS Advokatbyra has advised SynAct Pharma AB (publ). SynAct Pharma AB (publ) has completed a directed share issue, raising approximately SEK 51.9 million through an accelerated…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Maha Kanaan

Author: Maha Kanaan

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here